復旦復華(600624.SH):擬出資2800萬元參設復華龍章健康科技
格隆匯3月9日丨復旦復華(600624.SH)公佈,公司擬出資2800萬元人民幣與北京華濟堂國際醫藥研究院、北京中金髮展投資有限公司、上海上科科技投資有限公司共同投資設立復華龍章健康科技(上海)有限公司,公司將持有復華龍章健康科技(上海)有限公司28%的股權。
復華龍章健康科技(上海)有限公司註冊資本1億元人民幣,經營範圍包括許可項目:貨物進出口;技術進出口及一般項目:技術服務、技術開發、技術諮詢、技術交流、技術轉讓、技術推廣;消毒劑銷售(不含危險化學品);個人衞生用品銷售等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.